Scott Evans

Dr. Scott Evans is a Professor and Founding Chair of the Department of Biostatistics Bioinformatics and the Director of the George Washington Biostatistics Center. He is the Director of the Statistical and Data Management Center (SDMC) for the Antibacterial Resistance Leadership Group (ARLG). Professor Evans has been a member of an FDA Advisory Committee, and the Board of Directors for the American Statistical Association (ASA), the Society for Clinical Trials (SCT), and the Mu Sigma Rho (the National Honorary Society for Statistics). He is a member of the Steering Committee of the Clinical Trials Transformation Initiative (CTTI), the Executive Committee for the Analgesic, Anesthetic, and Addiction Clinical Trial Translations, Innovations, and Networks (ACTTION), and serves as the Co-chair of the Benefit-Risk Balance for Medicinal Products Working Group for the Council for International Organizations of Medical Sciences (CIOMS). His methodological contributions include the desirability of outcome ranking (DOOR), sequential multiple assignment randomized trials for comparing antibiotic strategies (SMART COMPASS), and benefit:risk evaluation for diagnostics: a framework (BED-FRAME). Professor Evans is the Editor-in-Chief of Statistical Communications in Infectious Diseases (SCID), and the Co-Editor of a Special Section of Clinical Infectious Diseases (CID) entitled Innovations in Design, Education, and Analysis (IDEA). Dr. Evans is a recipient of the Mosteller Statistician of the Year Award, the Robert Zackin Distinguished Collaborative Statistician Award for contributions to the AIDS Clinical Trials Group (ACTG), an elected member of the International Statistical Institute (ISI), and is a Fellow of the American Statistical Association (ASA), Society for Clinical Trials (SCT), and the Infectious Disease Society of America (IDSA).